VEGFA and dopa-responsive dystonia due to sepiapterin reductase deficiency: Specifically, corticosteroid treatment was indicated for treatment of SRD secondary to inflammation as in intermediate uveitis and VKH; however, in patients with SRD due to CNVM, anti-VEGF and anti-inflammatory medications were required.